Related Experiment Video
Updated: Jan 30, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
Long Non-Coding RNAs in Multiple Myeloma
Romana Butova1, Petra Vychytilova-Faltejskova2, Adela Souckova3
1Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic. romanabutova@gmail.com.
Abstract:
Multiple myeloma (MM) is the second most common hematooncological disease of malignant plasma cells in the bone marrow. While new treatment brought unprecedented increase of survival of patients, MM pathogenesis is yet to be clarified. Increasing evidence of expression of long non-coding RNA molecules (lncRNA) linked to development and progression of many tumors suggested their important role in tumorigenesis. To date, over 15,000 lncRNA molecules characterized by diversity of function and specificity of cell distribution were identified in the human genome. Due to their involvement in proliferation, apoptosis, metabolism, and differentiation, they have a key role in the biological processes and pathogenesis of many diseases, including MM. This review summarizes current knowledge of non-coding RNAs (ncRNA), especially lncRNAs, and their role in MM pathogenesis. Undeniable involvement of lncRNAs in MM development suggests their potential as biomarkers.
Insights
Long non-coding RNAs (lncRNAs) play a crucial role in multiple myeloma (MM) pathogenesis. Further research into lncRNAs may reveal novel biomarkers for this hematooncological malignancy.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Multiple myeloma (MM) is a significant hematooncological malignancy characterized by malignant plasma cells in the bone marrow.
- Despite advancements in treatment, the precise pathogenesis of MM remains incompletely understood.
- Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in the development and progression of various cancers, including MM.
Purpose of the Study:
- To review the current understanding of non-coding RNAs (ncRNAs), with a specific focus on lncRNAs.
- To elucidate the involvement and significance of lncRNAs in the pathogenesis of multiple myeloma.
- To explore the potential of lncRNAs as diagnostic or prognostic biomarkers for MM.
Main Methods:
- Literature review of existing research on ncRNAs and MM.
- Analysis of studies investigating lncRNA expression and function in MM.
- Synthesis of current knowledge regarding the biological roles of lncRNAs in MM development.
Main Results:
- Over 15,000 human lncRNA molecules have been identified, exhibiting diverse functions and cell-specific distributions.
- lncRNAs are implicated in fundamental biological processes such as proliferation, apoptosis, metabolism, and differentiation.
- Evidence strongly suggests the involvement of lncRNAs in the tumorigenesis and progression of multiple myeloma.
Conclusions:
- lncRNAs are integral to the biological processes underlying multiple myeloma.
- The established role of lncRNAs in MM development highlights their potential utility as biomarkers.
- Further investigation into lncRNAs could lead to novel diagnostic and therapeutic strategies for multiple myeloma.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
piRNA - Piwi-interacting RNAs
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Nursing Code of Ethics

